Transduction rate constant as more reliable index quantifying efficiency of retroviral gene delivery

Biotechnology and Bioengineering

Volumn 77, Issue 6, 2002, Pages 668-667

  Kwon, Young Jik ^a   Peng, Ching An ^a  

^a University of Southern California   (United States)

Author keywords

Infectious retroviral concentration; Retroviral gene delivery; Semi infinite domain; Transduction rate constant; VSV G pseudotyped retrovirus

Indexed keywords

CELL CULTURE; DIFFUSION; LAPLACE TRANSFORMS; TITRATION;

RETROVIRAL TRANSDUCTION;

GENETIC ENGINEERING;

RETROVIRUS VECTOR;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENETIC TRANSDUCTION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; RETROVIRUS; TARGET CELL; VIRAL GENE DELIVERY SYSTEM;

UNIDENTIFIED RETROVIRUS;

EID: 0037139748     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10214     Document Type: Article

References (31)

1. Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection
2. Retroviral transduction is limited by Brownian motion
3. Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers
4. The effect of hexadimethrine bromide (polybrene) on the infection of the primate retroviruses SSV 1/SSAV 1 and BaEV
5. Protamine suliate as an effective alternative to polybrene in retroviral-mediated gene-transfer: Implications for human gene therapy
6. High-liter packaging cells producing recombinant retroviruses resistant to human serum
7. pH-dependent fusion induced by vesicular stomatitis virus glycoprotein reconstituted into phospholipid vesicles
8. Über die von der molekularkinetischen theorie der wärme geforderte bewegung von in ruhenden flüssigkeiten suspendierten teilchen
9. Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium
10. Integration of retroviral DNA into the genome of the infected cell
11. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
12. Improved methods of retroviral vector transduction and production for gene therapy
13. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surfece virus receptor
14. Impact of cell growth morphology on retroviral transduction: Effect of contact inhibition
15. Enhanced retroviral transduction of 293 cells cultured on liquid interface
16. Kinetics of retrovirus production and decay
17. Temperature significantly affects retroviral vector production and deactivation rates, and thereby determines retroviral titers
18. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: Modulation by poloxamer 407 and implications for cardiovascular gene therapy
19. Design of retrovirus vectors for transfer and expression of the human B-globin gene
20. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
21. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
22. Retrovirus infection: Effect of time and target cell number
23. Gene therapy: The first decade
24. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
25. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction
26. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site?
27. Retroviral vector-mediated gene transfer into keratocytes: In vitro effects of polybrene and protamine sulfate
28. Multiplicity of infection/multiplicity of confusion
29. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: Improved safety and high titer
30. A simple procedure to determine the biological titer of recombinant retroviral vectors
31. Virus particle adsorption. I. Theory of adsorption and experiments in the attachment of particles to non-biological surfaces